Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial
Status:
Unknown status
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
Efficacy and safety of OctaplasLG® administration vs. crystalloids (standard) in patients
with septic shock - a randomized, controlled, open-label investigator-initiated pilot trial